Palivizumab Injection shortage

To Be Discontinued

Palivizumab Injection is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Antiviral

Dosage form

Injection

Routes

INTRAMUSCULAR

Last updated

08/13/2025

Strength variants

Not specified

Need sourcing help for Palivizumab Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Swedish Orphan Biovitrum AB866-773-5274
To Be Discontinued
Swedish Orphan Biovitrum AB866-773-5274
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Antiviral

Peginterferon alfa-2a Injection

Currently in Shortage

Category: Antiviral
Reason: Shortage of an active ingredient
Updated: 08/19/2025

Peginterferon alfa-2a Injection

Currently in Shortage

Category: Antiviral
Reason: Shortage of an active ingredient
Updated: 08/19/2025

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.